Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring
Author(s) -
Olivia Keiser,
Hannock Tweya,
Andrew Boulle,
Paula Braitstein,
Mauro Schecter,
Martin W. G. Brinkhof,
François Dabis,
Suely Tuboi,
Eduardo Sprinz,
Mar PujadesRodríguez,
Alexandra Calmy,
Nagalingeswaran Kumarasamy,
Denis Nash,
Andreas Jahn,
Patrick MacPhail,
R Lüthy,
Robin Wood,
Matthias Egger
Publication year - 2009
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32832e05b2
Subject(s) - viral load , interquartile range , medicine , hazard ratio , immunology , confidence interval , virology , human immunodeficiency virus (hiv)
In high-income countries, viral load is routinely measured to detect failure of antiretroviral therapy (ART) and guide switching to second-line ART. Viral load monitoring is not generally available in resource-limited settings. We examined switching from nonnucleoside reverse transcriptase inhibitor (NNRTI)-based first-line regimens to protease inhibitor-based regimens in Africa, South America and Asia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom